TELO Latest Press Releases

-- February 17, 2026 --

Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models ACCESS Newswire 8:00 AM

-- February 5, 2026 --

Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging ACCESS Newswire 8:00 AM

-- January 5, 2026 --

Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models ACCESS Newswire 8:00 AM

-- December 18, 2025 --

Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development ACCESS Newswire 7:30 AM

-- November 25, 2025 --

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells ACCESS Newswire 8:00 AM

-- November 21, 2025 --

Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells ACCESS Newswire 7:30 AM

-- November 12, 2025 --

Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line ACCESS Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software